Arkstone Next is here. Expert-in-the-loop AI clinical intelligence for clinics, urgent care and nursing homes.
See what's new Read the announcementAccurate infectious disease testing is only part of the job. Dr. Ari Frenkel and Kelly Chauvin, PharmD, of Molecular Testing Labs talk through the gap between the lab result and the treatment decision, and why it matters.
Why antimicrobial resistance (AMR) matters now, and the shortage of infectious disease expertise in most care settings.
Molecular Testing Labs on accuracy and quality, what their infectious disease panels identify and how they think about access to testing.
A detailed result arrives and the clinician still has to decide. What happens in that gap, and what changes when interpretation arrives with the result.
What was ordered, what came back, what was decided and what happened for the patient.
Dr. Frenkel moderates an open Q&A with the panel.
Co-founder and Chief Science Officer, Arkstone Medical Solutions
Infectious disease physician and co-founder of Arkstone, where he leads the clinical side of OneChoice®, Arkstone's interpretive reporting and antimicrobial decision support. He hosts the Prescribe Responsibly podcast.
Medical Science Liaison, Molecular Testing Labs
Pharmacist and medical science liaison at Molecular Testing Labs, a CLIA-certified, CAP-accredited high-complexity laboratory. Kelly helps providers understand what molecular panels detect and how to act on them responsibly.
Presented by Arkstone Medical Solutions with Molecular Testing Labs, an Arkstone Qualified Lab.
Sign in with Doximity, upload a lab report and receive a OneChoice report.
